Overview & Mechanism
The C-terminal tripeptide of alpha-melanocyte-stimulating hormone; exerts potent anti-inflammatory effects by inhibiting NF-κB and pro-inflammatory cytokines, particularly in the gut.
Research Dosage
100–500 mcg/day (or 1–5 mg/week)
Subcutaneous injection or oral
Once daily
4–8 weeks
Reconstitution & Storage
Reconstitute a 10 mg vial with 2 mL of bacteriostatic water (5 mg/mL).
Lyophilized: −20 °C. Reconstituted: refrigerate 2–8 °C, use within 28–30 days.
Safety & Side Effects
Potent anti-inflammatory; well tolerated in research.
Studies
KPV anti-inflammatory effects in colitis
KPV reduced intestinal inflammation in experimental colitis models by inhibiting NF-κB and pro-inflammatory cytokines.
Read studyReferences
Research Use Only
This information is intended for licensed researchers and educational purposes only. It does not constitute medical advice. PureLife Health products are not approved for human use by Health Canada or the FDA. Always consult a qualified medical professional and verify against current literature.